Growth Metrics

Protalix BioTherapeutics (PLX) FCF Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 723.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,066.00
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 9,827.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9,827.00
Dec 31, 2025 6,133.00
Sep 30, 2025 4,207.00
Jun 30, 2025 4,695.00
Mar 31, 2025 -1,657.00
Dec 31, 2024 8,996.00
Sep 30, 2024 3,721.00
Jun 30, 2024 -12,026.00
Mar 31, 2024 18,607.00
Dec 31, 2023 6,925.00
Sep 30, 2023 -3,031.00
Jun 30, 2023 8,697.00
Mar 31, 2023 -67.00
Dec 31, 2022 -679.00
Sep 30, 2022 -4,038.00
Jun 30, 2022 -3,983.00
Mar 31, 2022 3,367.00
Dec 31, 2021 14,773.00
Sep 30, 2021 -205,993.00
Jun 30, 2021 50,125.00
Mar 31, 2021 12,193.00
Dec 31, 2020 -100,596.00
Sep 30, 2020 10,906.00
Jun 30, 2020 6,535.00
Mar 31, 2020 49,950.00
Dec 31, 2019 33,598.00
Sep 30, 2019 5,147.00
Jun 30, 2019 65,692.00
Mar 31, 2019 133,059.00
Sep 30, 2018 279,253.00
Jun 30, 2018 -6,090.00
Mar 31, 2018 15,812.00
Mar 31, 2017 -40,421.00
Dec 31, 2016 -33,792.00
Sep 30, 2016 29,718.00
Jun 30, 2016 -31,039.00
Mar 31, 2016 -111,526.00
Sep 30, 2015 -51,477.00
Jun 30, 2015 -39,269.00
Mar 31, 2015 -18,667.00
Mar 31, 2014 3,121.00
Dec 31, 2013 75,041.00
Sep 30, 2013 -2,784.00